Autologous Mesenchymal Stromal Cells Secreting Neurotrophic Factors
Chronic Progressive Multiple Sclerosis
Brainstorm-Cell TherapeuticsCell therapyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
12 Active assets in the Chronic Progressive Multiple Sclerosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
D-Thioctic Acid Rebecca Spain | Phase 2/3 | BB |
Cyclophosphamide Bruce Cree | Phase 3 | BB |
Rituximab Centre Hospitalier de PAU | Phase 2 | B |
Masitinib AB Science | Phase 3 | B |
Cladribine Queen Mary University of London | Phase 2/3 | B |
View all 29 →
Same molecule, other indications
Autologous Mesenchymal Stromal Cells Secreting Neurotrophic Factors is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →